Abstract Sat1305: During endurance races: half of sudden cardiac arrest cases remain unexplained.

R Richard Chocron (Paris Cardiac Arrest Center, Paris, France) T Thomas Laurenceau (Paris Cardiac Arrest Center, Paris, France) M Marion Chabrol (Paris Cardiac Arrest Center, Paris, France) S Soline Mignot (Paris Cardiac Arrest Center, Paris, France) U Ugo Meli (Inserm u970, Paris, France) C Camille Langlois (Paris Cardiac Arrest Center, Paris, France) P Pierre Cezard (Paris Cardiac Arrest Center, Paris, France) P Peter Schwartz (IRCCS ISTITUTO AUXOLOGICO ITALIANO, Milano, Italy) S Stefan Kääb B Bernard LEVY (Inserm, Paris, France) F Franckie Beganton (Paris Cardiac Arrest Center, Paris, France) W Wulfran Bougouin (Inserm u970, Paris, France) J Jean-Philippe Empana (Inserm u970, Paris, France) X Xavier Jouven (Paris Cardiac Arrest Center, Paris, France)

Abstract

Background: Sport-related Sudden Cardiac Arrest (Sr-SCA) can occur even apparently healthy athletes. Cardiomyopathies and channelopathies have consistently been implicated as leading causes of SCA in young competitive athletes. However, these findings may not fully apply to long-distance runners, who tend to be older and present with different cardiovascular risk factors and pre-existing conditions leading to ischemic diseases. Method: We merged two prospectively collected databases. The first source was a regional registry that recorded 55000 out-of-hospital cardiac arrests in adults (October 2011 – April 2024). The second source contained official participation lists for 20 km race, half-marathon (HM) and full marathon (FM) for the same period (all years except 2020). Only finishers and Sr-SCA events were analyzed. Comprehensive in-hospital work-up included ECG, echocardiography, coronary angiography, cardiac MRI and drug-provocation tests; when indicated, electrophysiological study, Holter monitoring, signal-averaged ECG, endomyocardial biopsy and genetic testing were added. Results: Over the past 10 years, among 1.2 million participants (mean age 38 ± 11 years, 71.6% men), there were 17 SCA cases (7 in 20km, 5 in HM and 5 in FM). Among these cases, 88% (15/17) were men, with a mean age of 42 ± 13 years. Etiology remained undetermined in 8 cases (47.1 %) despite exhaustive evaluation (Figure 1). A cause was identified in 8 patients: ischemic cardiomyopathy (n=5), Brugada syndrome (n=1), myocarditis (n=1), and an anomalous right coronary artery (n=1). One patient carried heterozygous SCN5A and VCL variants that may explain the Sr-SCA. Ischemic cardiomyopathy accounted for 60% (3/5) of FM cases, 20% (1/5) of HM cases and 14.3% (1/7) of 20 km race cases. Conclusion: Despite extensive in-hospital medical assessments, half of the cases remained unexplained. These results contribute to the ongoing debate on pre-participation screening in sport and the proposed strategies to mitigate the occurrence of Sr-SCA.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (14)

R

Richard Chocron

Paris Cardiac Arrest Center, Paris, France

T

Thomas Laurenceau

Paris Cardiac Arrest Center, Paris, France

M

Marion Chabrol

Paris Cardiac Arrest Center, Paris, France

S

Soline Mignot

Paris Cardiac Arrest Center, Paris, France

U

Ugo Meli

Inserm u970, Paris, France

C

Camille Langlois

Paris Cardiac Arrest Center, Paris, France

P

Pierre Cezard

Paris Cardiac Arrest Center, Paris, France

P

Peter Schwartz

IRCCS ISTITUTO AUXOLOGICO ITALIANO, Milano, Italy

S

Stefan Kääb

B

Bernard LEVY

Inserm, Paris, France

F

Franckie Beganton

Paris Cardiac Arrest Center, Paris, France

W

Wulfran Bougouin

Inserm u970, Paris, France

J

Jean-Philippe Empana

Inserm u970, Paris, France

X

Xavier Jouven

Paris Cardiac Arrest Center, Paris, France